Skip to main content

Table 2 ECG and laboratory findings in the VT and Non-VT group

From: The relationship between J wave and ventricular tachycardia during Takotsubo cardiomyopathy

 

Total (n = 79)

VT group (n = 20)

Non-VT group (n = 59)

P value

Electrocardiographic changes

Atrial arrhythmia, n (%)

26 (33)

12 (60)

14 (25)

0.003

AV block, n (%)

2 (2)

0 (0)

2 (3)

1.000

ST-segment elevation, n (%)

36 (45)

9 (45)

27 (45)

1.000

T-wave inversion, n (%)

55 (68)

16 (80)

39 (65)

0.27

Q wave, n (%)

18 (22)

4 (20)

14 (23)

0.51

QTc interval, ms

545.2 ± 63.6

577.0 ± 58.5

534.2 ± 61.1

0.01

Laboratory findings

Sodium, mmol/L

139.1 ± 4.9

139.6 ± 5.9

138.9 ± 4.6

0.59

Potassium, mmol/L

4.1 ± 0.7

3.9 ± 0.8

4.1 ± 0.7

0.64

Ionized calcium, mg/dL

0.96 ± 0.1

0.95 ± 0.1

0.97 ± 0.1

0.51

Magnesium, mg/dL

2.1 ± 0.4

2.1 ± 0.4

2.2 ± 0.4

0.16

Cardiac enzymes

Peak CK, ng/mL

827.2 ± 1409.9

1008.5 ± 1634.4

766.7 ± 1336.7

0.51

Peak CK-MB, ng/mL

30.7 ± 46.9

49.1 ± 69.7

24.7 ± 35.1

0.15

Peak troponin-I, ng/mL

9.8 ± 20.6

16.5 ± 34.1

7.7 ± 13.3

0.28

NT-proBNP, pg/mL

12900.2 ± 13370.2

14179.8 ± 13207.2

12293.6 ± 13499.0

0.28

  1. Values are mean ± SD or number (%); VT ventricular tachycardia; Atrial arrhythmia: PSVT, atrial tachycardia, atrial fibrillation; CK creatine kinase; CK-MB creatine kinase-myocardial band; NT-proBNP N-terminal pro-brain natriuretic peptide